JOHN GOLL - 17 Feb 2026 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role: SVP, FINANCE & CAO
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Issuer symbol: IMCR
Transactions as of: 17 Feb 2026
Net transactions value: -$22,580
Form type: 4
Filing time: 19 Feb 2026, 17:00:17 UTC
Previous filing: 19 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GOLL JOHN	SVP, FINANCE & CAO	C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM	/s/ Lily Hepworth, Attorney-in-Fact	19 Feb 2026	0001779466

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMCR	Ordinary Shares	Options Exercise	$0	+1,351		$0.000000	1,351	17 Feb 2026	Direct	F1
transaction	IMCR	Ordinary Shares	Sale	$22,580	-698	-52%	$32.35	653	18 Feb 2026	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMCR	Restricted Share Units	Options Exercise	$0	-1,351	-25%	$0.000000	4,054	17 Feb 2026	Ordinary Shares	1,351		Direct	F1, F4, F5
transaction	IMCR	Restricted Share Units	Award	$0	+7,411		$0.000000	7,411	17 Feb 2026	Ordinary Shares	7,411		Direct	F1, F4, F6
transaction	IMCR	Employee Share Option (Right to Buy)	Award	$0	+21,252		$0.000000	21,252	17 Feb 2026	Ordinary Shares	21,252	$32.38	Direct	F1, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.
F2	The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share units ("RSUs") .
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.18 to $32.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Each RSU represents a contingent right to receive one Ordinary Share.
F5	On February 17, 2025, the Reporting Person was granted 5,405 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date.
F6	The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date.
F7	25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.